Vanda Pharmaceuticals (VNDA) Depreciation Expense (2017 - 2025)
Historic Depreciation Expense for Vanda Pharmaceuticals (VNDA) over the last 9 years, with Q3 2025 value amounting to $301000.0.
- Vanda Pharmaceuticals' Depreciation Expense rose 3935.19% to $301000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 2586.0%. This contributed to the annual value of $900000.0 for FY2024, which is 217.39% down from last year.
- According to the latest figures from Q3 2025, Vanda Pharmaceuticals' Depreciation Expense is $301000.0, which was up 3935.19% from $267000.0 recorded in Q2 2025.
- In the past 5 years, Vanda Pharmaceuticals' Depreciation Expense registered a high of $374000.0 during Q4 2021, and its lowest value of $200000.0 during Q3 2023.
- In the last 5 years, Vanda Pharmaceuticals' Depreciation Expense had a median value of $284000.0 in 2022 and averaged $275578.9.
- Per our database at Business Quant, Vanda Pharmaceuticals' Depreciation Expense plummeted by 3311.04% in 2023 and then soared by 3935.19% in 2025.
- Vanda Pharmaceuticals' Depreciation Expense (Quarter) stood at $374000.0 in 2021, then decreased by 24.06% to $284000.0 in 2022, then fell by 27.82% to $205000.0 in 2023, then grew by 27.8% to $262000.0 in 2024, then rose by 14.89% to $301000.0 in 2025.
- Its last three reported values are $301000.0 in Q3 2025, $267000.0 for Q2 2025, and $231000.0 during Q1 2025.